Sort   by:  
 Page size 
UnknownTreatment-Shortening Effect of a Novel Regimen Combining Clofazimine and High-Dose Rifapentine in Pathologically Distinct Mouse Models of Tuberculosis.
Not available
S-EPMC6535519 | biostudies-literature
UnknownCompletion, safety, and efficacy of tuberculosis preventive treatment regimens containing rifampicin or rifapentine: an individual patient data network meta-analysis.
Not available
S-EPMC11068309 | biostudies-literature
UnknownAn evaluation of a choice architecture-based intervention on prescribing of TB preventive treatment to people living with HIV in southern Africa (the CAT study): a cluster-randomised trial.
Not available
S-EPMC12104925 | biostudies-literature
UnknownImpact of Clofazimine Dosing on Treatment Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis.
Not available
S-EPMC6021677 | biostudies-literature
UnknownEfficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes.
Not available
S-EPMC11878306 | biostudies-literature
UnknownEfavirenz Pharmacokinetics and Human Immunodeficiency Virus Type 1 (HIV-1) Viral Suppression Among Patients Receiving Tuberculosis Treatment Containing Daily High-Dose Rifapentine.
Not available
S-EPMC9890454 | biostudies-literature
UnknownRifapentine With and Without Moxifloxacin for Pulmonary Tuberculosis in People With Human Immunodeficiency Virus (S31/A5349).
Not available
S-EPMC10169427 | biostudies-literature
UnknownClinical standards for the diagnosis, treatment and prevention of TB infection.
Not available
S-EPMC8886963 | biostudies-literature
UnknownHuman-specific tandem repeat expansion and differential gene expression during primate evolution.
Not available
S-EPMC6859368 | biostudies-literature
UnknownAn integrated map of structural variation in 2,504 human genomes.
Not available
S-EPMC4617611 | biostudies-literature
Sort   by:  
 Page size